Research Use Only Notice: The compounds discussed in this guide are research peptides intended for in-vitro and animal research applications only. None are FDA-approved for therapeutic human use. Nothing in this article constitutes medical advice or guidance for human longevity protocols.
Peptides for anti-aging and longevity research span several distinct compound families — telomere-related sequences, growth hormone secretagogues, mitochondrial peptides, copper-binding tripeptides, and immune-modulating compounds. Each acts through a different biological pathway, and each is studied for different aspects of cellular and organismal aging in research models. This guide from the chemistry team at OPS Peptide Science walks through the six most-studied anti-aging research peptides — Epitalon, CJC-1295 + Ipamorelin, MOTS-c, SS-31, GHK-Cu, and Thymosin Alpha-1 — including their proposed mechanisms and current research status.
For practical research workflow guidance, see our companion posts on how to reconstitute peptides, how to inject peptides, and peptide stability and storage.
What Are Anti-Aging Peptides? Research Categories
The category “anti-aging peptides” is a functional grouping rather than a chemical one. Research compounds fall into this bucket when they’re studied for endpoints related to:
- Telomere length and replicative senescence — markers of cellular aging at the chromosomal level
- Mitochondrial function — energy production efficiency that declines with age
- Growth hormone axis modulation — endocrine pathways that decline across adulthood
- Cellular repair and regeneration — gene expression patterns associated with younger biological states
- Immunosenescence — age-related decline in immune function
- Oxidative stress and reactive oxygen species — molecular damage accumulating with age
Each of the peptides in this guide is studied within one or more of these research framings. None are FDA-approved as anti-aging therapeutics — they exist within the research-chemical pathway, sold to laboratories under research-use-only labeling.
The broader longevity-peptide research literature is searchable through PubMed’s aging and peptide research database.

Epitalon — Pineal and Telomere Research
Epitalon is a four-amino-acid synthetic peptide (Ala-Glu-Asp-Gly) developed from research on pineal gland extracts. It has the most published research among peptides studied specifically for telomere-related endpoints in aging models.
Research applications documented:
- Telomerase activation in cell culture studies
- Telomere length measurements in animal aging models
- Melatonin synthesis modulation through pineal effects
- Circadian rhythm research
- Antioxidant marker changes in research subjects
Proposed mechanism: Research literature describes Epitalon as a peptide regulator of pineal gland function with downstream effects on telomerase activity. The mechanism is studied primarily through Russian research programs spanning several decades; Western research has reproduced portions of these findings but the full mechanism remains incompletely characterized.
Research administration: Subcutaneous injection in animal research models. Short half-life leads to daily or twice-daily dosing in most published protocols. Cycle-based research designs (10–20 day cycles with washout periods) are common.
Regulatory status: Not FDA-approved. Available legally as a research chemical with research-use-only labeling.
CJC-1295 + Ipamorelin — Growth Hormone Axis
CJC-1295 and Ipamorelin are commonly studied as a combined growth hormone secretagogue protocol. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog; Ipamorelin is a growth hormone-releasing peptide (GHRP). The two act on different receptors but converge on the same downstream pathway — increased pulsatile growth hormone release.
Research applications documented:
- Growth hormone release studies in animal and human research
- IGF-1 trajectory studies
- Body composition research in aging models
- Sleep quality research (growth hormone is closely linked to slow-wave sleep)
- Bone density studies
Proposed mechanism: CJC-1295 binds GHRH receptors on somatotrophs in the anterior pituitary; Ipamorelin binds the ghrelin/GHS-R receptor. Combined administration produces additive growth hormone release compared to either alone. The mechanism is well-characterized — these are among the most-studied growth hormone secretagogues in research literature.
Research administration: Subcutaneous injection in research models, typically before sleep to align with natural growth hormone release patterns. Cycle-based protocols are common in research designs.
Regulatory status: Not FDA-approved. WADA prohibited in athletic competition. Available legally as a research chemical with research-use-only labeling.

MOTS-c — Mitochondrial-Derived Peptide
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA rather than nuclear DNA — making it one of a small group of mitochondrial-derived peptides identified in modern research. It has become a focal compound in metabolic and aging research over the past decade.
Research applications documented:
- Insulin sensitivity studies in animal models
- Mitochondrial biogenesis research
- Glucose homeostasis
- Skeletal muscle metabolism in aging models
- Exercise mimicry research — MOTS-c levels rise with exercise in published studies
Proposed mechanism: MOTS-c appears to act through AMPK activation and modulation of folate-methionine cycles, with downstream effects on cellular energy metabolism. The mitochondrial origin makes it distinct from nuclearly-encoded peptides and has driven research interest in mitochondrial-nuclear signaling more broadly.
Research administration: Subcutaneous or intraperitoneal injection in animal research models. Dosing protocols vary across published studies.
Regulatory status: Not FDA-approved. Available as a research chemical with research-use-only labeling.
SS-31 (Elamipretide) — Mitochondrial Membrane Peptide
SS-31, also known as elamipretide, is a small synthetic peptide that targets the inner mitochondrial membrane through cardiolipin binding. Unlike MOTS-c, SS-31 acts at the structural level of mitochondrial membranes rather than through gene-expression pathways.
Research applications documented:
- Mitochondrial dysfunction in cardiac research models
- Reactive oxygen species reduction studies
- Heart failure research (clinical trials have been conducted internationally)
- Neurodegeneration research models
- Muscle function in aging research
Proposed mechanism: SS-31 binds cardiolipin in the inner mitochondrial membrane, stabilizing membrane architecture and improving electron transport chain efficiency. The mechanism is well-characterized at the structural level and supported by extensive cardiac research literature.
Research administration: Subcutaneous injection in research models. Has been studied in clinical trials internationally though not FDA-approved.
Regulatory status: Not FDA-approved. Available as a research chemical with research-use-only labeling.
GHK-Cu — Copper Peptide in Aging Research
GHK-Cu was introduced in the healing-peptides discussion but also occupies a prominent place in anti-aging research due to its declining endogenous levels with age and its documented effects on gene expression patterns associated with younger biological states.
Anti-aging research applications:
- Gene expression studies showing modulation of hundreds of genes related to aging
- Skin biology research (collagen, elastin, fibroblast function)
- Hair follicle stem cell research
- Cognitive aging research models
- Antioxidant enzyme system effects
Published research has documented that GHK-Cu modulates expression of genes associated with cellular senescence, DNA repair, and oxidative stress response — a profile that has driven its inclusion in aging research alongside its more established applications in wound healing and skin biology.
Thymosin Alpha-1 — Immune Aging Research
Thymosin Alpha-1 enters anti-aging research through immunosenescence — the age-related decline in immune function. The thymus gland atrophies progressively across adulthood, and the resulting decline in T-cell function is one of the most robust biomarkers of biological aging.
Research interest in Thymosin Alpha-1 for aging includes:
- Immune reconstitution research in aging models
- Vaccine response in older research subjects
- Chronic infection susceptibility studies
- Thymic involution modulation
Combined with its established hepatitis and immune-recovery research (covered in our companion guide on healing peptides), Thymosin Alpha-1 is one of the more thoroughly studied peptides across both healing and anti-aging research applications.
How Anti-Aging Peptides Are Studied in Research
Anti-aging research uses several specialized methodologies beyond standard pre-clinical study design:
- Senescence markers — measuring cellular markers of replicative aging (p16, β-galactosidase activity, telomere length)
- Mitochondrial assays — oxygen consumption, ATP production, membrane potential measurements
- Lifespan studies — long-running animal-model research measuring survival curves under different peptide protocols
- Healthspan endpoints — functional measures of aging (grip strength, cognitive performance, mobility scores)
- Gene expression profiling — RNA-seq and similar techniques to characterize cellular response to peptide exposure
- Biological age clocks — DNA methylation-based age estimation in research subjects
The NCBI/PMC aging-peptide animal research database documents these methodologies across the compounds discussed in this guide.

FAQ
What are the best peptides for anti-aging research?
The most-studied anti-aging research peptides include Epitalon (telomere/pineal research), CJC-1295 + Ipamorelin (growth hormone axis), MOTS-c (mitochondrial-derived), SS-31 (mitochondrial membrane), GHK-Cu (copper peptide), and Thymosin Alpha-1 (immune aging). Each addresses different aspects of aging biology — no single peptide covers all of them.
Are anti-aging peptides FDA-approved?
No. None of the peptides discussed in this guide are FDA-approved as anti-aging therapeutics for human use. They are sold legally in the US as research chemicals with research-use-only labeling for laboratory and research applications.
What is the difference between MOTS-c and SS-31?
Both target mitochondria but through different mechanisms. MOTS-c is mitochondrial-encoded and acts through AMPK and gene expression pathways. SS-31 is synthetic and acts at the inner mitochondrial membrane structurally, binding cardiolipin to stabilize the membrane. They address different aspects of mitochondrial function.
How long do anti-aging peptide research protocols typically run?
Research timelines vary widely. Mechanistic studies in cell culture run days to weeks. Animal aging-marker studies typically run 4–12 weeks. Lifespan studies can run years. Cycle-based protocols (e.g., 10–20 day on / 10–20 day off) are common in many published peptide research designs.
Can anti-aging peptides be combined in research?
Combination protocols appear in research literature, with CJC-1295 + Ipamorelin being the most documented example. Combining peptides that act through different mechanisms (mitochondrial + growth hormone + immune) is a recurring research design. Combination studies require careful protocol design to characterize each compound’s individual and additive contributions.
Anti-aging peptide research is one of the most active areas in modern longevity science — spanning telomere biology, mitochondrial function, growth hormone modulation, copper-dependent gene expression, and immunosenescence. The six peptides in this guide each address a different mechanism, and the published research literature continues to expand the picture of how these compounds influence cellular and organismal aging in research models.
For research-grade anti-aging peptides backed by per-lot Certificates of Analysis and full HPLC-MS purity documentation, browse the OPS Peptide Science catalog, visit the OPS Peptide Science homepage for the full product overview, or verify a specific lot using its COA code.
Author: Shane Straight, Principal Chemist, OPS Peptide Science
Reviewed: May 2026

